Roles for KRAS in Pancreatic Tumor Development and Progression
Top Cited Papers
Open Access
- 1 May 2013
- journal article
- review article
- Published by Elsevier BV in Gastroenterology
- Vol. 144 (6), 1220-1229
- https://doi.org/10.1053/j.gastro.2013.01.071
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic CancerCancer Cell, 2012
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced SenescenceCancer Cell, 2011
- Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and ProgressionCancer Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Oncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal CellsCancer Cell, 2010
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell SurvivalCancer Cell, 2009
- Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic KrasBiochemical and Biophysical Research Communications, 2009
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007